PUBLISHER: GlobalData | PRODUCT CODE: 1535220
PUBLISHER: GlobalData | PRODUCT CODE: 1535220
Mechanical Circulatory Support Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Cardiovascular Devices therapeutic area.
Mechanical Circulatory Support Devices are devices which replace or assist the pumping function of the ventricles. Mechanical Circulatory Support Devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy.
Mechanical Circulatory Support Devices can be used as three therapy options, namely: Bridge to Transplant Therapy, Destination Therapy and Bridge to Recovery Therapy. Bridge to Transplant is a therapy where a patient who is waiting for a transplant is implanted with a device to keep them stable until transplant. Destination Therapy refers to the usage of the device permanently in a patient who is not eligible for a transplant. Bridge to Recovery Therapy refers to the temporary implantation of the device to support the recovery of a patient. Ventricular Assist Devices are most commonly used for Bridge to Transplant Therapy and Destination Therapy.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Mechanical Circulatory Support Devices and evolving competitive landscape -
Global, Regional, and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Syncardia Systems LLC, Berlin Heart GmbH, Jarvik Heart Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -